Description
Drospifem 20 (Ethinylestradiol, Drospirenone) Coated Tablets 0.02 mg/3 mg. №28
Ingredients
Each coated tablet contains 0.02 mg of ethinylestradiol and 3 mg of drospirenone.
Mechanism of Action
Drospifem 20 works by inhibiting ovulation, thickening cervical mucus, and altering the endometrium, preventing fertilization and implantation.
Pharmacological Properties
Drospifem 20 contains ethinylestradiol and drospirenone, which act synergistically to provide contraceptive effects.
Indications for Use
Drospifem 20 is indicated for the prevention of pregnancy, treatment of premenstrual dysphoric disorder (PMDD), and moderate acne in women seeking contraception.
Contraindications
Avoid using Drospifem 20 if pregnant, with a history of blood clots, certain cancers, or liver disease. Consult your healthcare provider before starting treatment.
Side Effects
Common side effects may include nausea, headache, breast tenderness, and breakthrough bleeding. Contact your healthcare provider if severe side effects occur.
Usage Instructions
Take one tablet daily for 28 days, starting on the first day of the menstrual cycle. Administer at the same time each day with or without food.
Benefits Compared to Analogues
Drospifem 20 has demonstrated efficacy similar to other combined oral contraceptives in preventing pregnancy, with a comparable side effect profile.
Suitable Patient Groups
Drospifem 20 is suitable for use in adult women of reproductive age. Consult a healthcare provider for specific recommendations for children, elderly, or other special populations.
Storage and Shelf Life
Store Drospifem 20 in a cool, dry place away from direct sunlight. Check the expiry date on the packaging and do not use after the stated shelf life.
Packaging Description
Drospifem 20 is available in packs containing 28 coated tablets. Each tablet is individually sealed for protection and labeled with dosage information.
Clinical Evidence and Proven Effectiveness
Research studies have confirmed the high efficacy of ethinylestradiol and drospirenone in Drospifem 20 for pregnancy prevention. Clinical trials have shown its effectiveness in managing PMDD symptoms and acne.
